Top Markets
#1 Pleasing Gold Pleasing Gold +1,498.13%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.53%
#4 BOOK OF MEME BOOK OF MEME +29.96%
#5 Ontology Gas Ontology Gas +28.98%
#6 Neiro Neiro +24.50%
#7 ConstitutionDAO ConstitutionDAO +24.22%
#8 Pump.fun Pump.fun +20.90%
#9 Unit Pump Unit Pump +20.90%
#10 Nockchain Nockchain +19.89%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Kedudukan dalam Saham #26417
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Harga Saham
$1.10
Modal Pasaran
$40.76M
Perubahan (1 hari)
3.68%
Perubahan (1 tahun)
-13.12%
Negara
JP
Perdagangan PRISM BioLab Co.,LTD (206A)

Kategori

Healthcare
Pendapatan untuk PRISM BioLab Co.,LTD (206A)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini PRISM BioLab Co.,LTD, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi PRISM BioLab Co.,LTD dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US